The Moving Average Convergence Divergence (MACD) for NSVGF turned positive on December 03, 2024. Looking at past instances where NSVGF's MACD turned positive, the stock continued to rise in of 72 cases over the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on November 27, 2024. You may want to consider a long position or call options on NSVGF as a result. In of 120 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. NSVGF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (7.608). NSVGF has a moderately low P/E Ratio (0.000) as compared to the industry average of (28.511). NSVGF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (4.521). NSVGF has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.032). NSVGF's P/S Ratio (714.286) is very high in comparison to the industry average of (33.632).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NSVGF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry MedicalDistributors